Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

COPD: illness severity, resource utilisation and cost.

Aodan J Tynan1, S J Lane

  • 1Medical Department, GlaxoSmithKline, Rathfarnham, Dublin 16, Ireland. aodan.j.tynan@gsk.com

Irish Medical Journal
|April 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Photoperiod, but not testosterone, increases basal metabolic rate in house sparrows.

Integrative organismal biology (Oxford, England)·2026
Same author

A Mathematical Modeling Approach to the Cort-Fitness Hypothesis.

Integrative organismal biology (Oxford, England)·2021
Same author

Time to improve training for hypoxic pulmonary challenge test.

QJM : monthly journal of the Association of Physicians·2018
Same author

A brief survey of clinicians' perceptions of parent preferences for involvement in obstetrical and perinatal management decisions in haemophilia.

Haemophilia : the official journal of the World Federation of Hemophilia·2018
Same author

Habitat switching by dark-bellied brent geese Branta b. bernicla (L.) in relation to food depletion.

Oecologia·2017
Same author

Beware of the devastating pulmonary aspergillosis syndromes in certain environments.

Irish medical journal·2016
Same journal

Unlocking the potential of electronic health records for research purposes.

Irish medical journal·2026
Same journal

ICU Handover: A Persistent Vulnerability in Critical Care Settings.

Irish medical journal·2026
Same journal

The Sugar-Sweetened Beverage Tax (Sugar Tax): Innovation and Stasis.

Irish medical journal·2026
Same journal

Gastrointestinal trichobezoars presenting as abdominal pain and obstruction - Rapunzel syndrome.

Irish medical journal·2026
Same journal

When Sepsis Kills: A Fatal Cascade of Invasive Group A Streptococcal Sepsis.

Irish medical journal·2026
Same journal

Fulminant Thrombotic Thrombocytopenic Purpura presenting through the FAST Stroke Pathway.

Irish medical journal·2026
See all related articles

The average direct cost for Chronic Obstructive Pulmonary Disease (COPD) in Irish secondary care is 4,730 euros, primarily driven by hospital admissions. Reducing illness severity could significantly lower these costs.

Area of Science:

  • Pulmonary Medicine
  • Health Economics

Background:

  • Chronic Obstructive Pulmonary Disease (COPD) is a significant cause of mortality and morbidity globally.
  • International evidence highlights the substantial financial burden associated with COPD management.

Purpose of the Study:

  • To quantify the direct and indirect costs of COPD within an Irish secondary care setting.
  • To identify the primary cost drivers and their relationship with disease severity.

Main Methods:

  • A study involving 150 COPD patients attending a respiratory clinic.
  • Collection of data on healthcare utilization, prescriptions, and clinical severity from patient records.
  • Estimation of direct costs and lost productivity.

Main Results:

Related Experiment Videos

  • The average direct cost of COPD was estimated at 4,730 euros per patient.
  • Secondary care costs represented 44% of the total expenditure.
  • In-patient admissions were the main driver of direct costs.
  • A positive correlation was observed between direct costs and both clinical and symptom severity.

Conclusions:

  • COPD costs escalate with increasing illness severity, largely due to secondary care in-patient expenses.
  • Slowing disease progression and reducing symptom severity may lead to substantial healthcare savings.
  • Potential exists to free up healthcare resources through effective COPD management and intervention.